News

IMRIC is on the move, raising awareness and working towards biomedical breakthroughs across Canada and Israel. Keep up with all of the latest IMRIC news and events here.

IMRIC’S Yuval Dor One Of Four Recipients Of Merck $1 Million Grant For Multiple Sclerosis Innovation

Merck, a leading science and technology company, announced recipients of the fourth annual Grant for Multiple Sclerosis Innovation (GMSI) during a symposium at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in London. This year, 260 proposals from 45 countries were submitted, representing innovative research projects taking place across the globe. Four research teams from the United Kingdom, Spain, Canada, Israel, Germany and Qatar were selected to share in the €1 million grant to support their research.

RenewSense Enters Brainnovation, Israel's Brain Technologies Accelerator

Prof. Amir Amedi
Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, today announced that RenewSense was selected to enter Brainnovation, Israel's Brain Technologies accelerator.

IMRIC Scientist Awarded For Work In Stem Cells & Regenerative Medicine

Dr. Yosef Buganim

Dr. Yosef Buganim is a young researcher at the Institute for Medical Research Israel-Canada (IMRIC), part of the Hebrew University’s Faculty of Medicine